Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin liquid add-on to morphine for pediatric chronic neuropathic or mixed pain
2014-004897-40Phase 2Terminated
- Sponsor
- Pharm
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic neuropathic pain and chronic pain comparing Gabapentin + morphine with Placebo + morphine (2 arms). Primary endpoint: Average pain score at end of treatment. Started Apr 2017; status: terminated.
02
Drugs
gabapentin
03
Conditions
chronic neuropathic painchronic pain
Beyond the preview
Go deeper on 2014-004897-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004897-40.